肌少-骨质疏松症专家共识

肌少-骨质疏松症已成为全球性的公共健康问题和前沿研究难题。目前仍存在对肌少-骨质疏松症的临床知晓率低、重视不够、诊断治疗方法单一、管理不完善等实际问题。中国健康促进基金会组织专家编写《肌少-骨质疏松症专家共识》，为肌少-骨质疏松症的临床诊疗和科学研究提供参考。共识论述了肌少-骨质疏松症是肌少症和骨质疏松症并存的退行性代谢综合征，有共同的发病基础，诊断标准应是骨质疏松症与肌少症并存，预防比治疗更重要。肌少-骨质疏松症的治疗目标是改善肌量、肌力、身体平衡、骨量和骨质量，避免出现跌倒和骨折。肌少-骨质疏松症的管理应肌骨并重，综合诊断、规范治疗，医患合作，建立科学评估、定期随访机制。

Sarcopenia-osteoporosis expert consensus

Sarcopenia-osteoporosis has become a global public health problem and frontier research problem. At present, there are still some practical problems such as single diagnosis and treatment, and imperfect management of sarcopenia-osteoporosis. The China Health Promotion Foundation organized experts to compile the Expert Consensus on sarcopenia-osteoporosis to provide reference for the clinical diagnosis, treatment and scientific research of sarcopenia-osteoporosis. The consensus discussed: sarcopenia-osteoporosis is a degenerative metabolic syndrome coexisting with sarcopenia and osteoporosis, has a common basis of pathogenesis, the diagnostic criteria should be osteoporosis and sarcopenia coexisting, prevention is more important than treatment. The goal of treatment for sarcopenia-osteoporosis is to improve muscle mass, muscle strength, body balance, bone mass, and bone quality, and to avoid falls and fractures. The management of sarcopenia-osteoporosis should pay equal attention to muscle and bone, based on comprehensive diagnosis, standardized treatment, doctor-patient cooperation, scientific evaluation and regular follow-up mechanism.